Presented by
Management Forum
Effective Technology Transfer Training Course
The ‘how to’ of technology transfer across the product lifecycle.
★★★★★ "The theoretical part was interesting, but the practical excercises proposed during the course were s... more (22)"
2-3 June 2025
+ 6-7 October 2025 »
from £1299
- Format: Live online
- CPD: 12 hours for your records
- Certificate of completion
Course overview
Technology transfer (TT) is an increasingly important part of the pharmaceutical industry, with companies expanding the use of third parties for both development and manufacture.
There are few formal guidelines around this subject, but regulators expect companies to get it right for both internal and external transfers. Poorly run transfers can be costly and impact product quality, whereas well-run transfers bring business benefits and assure product quality.
Attending this highly practical course will give participants the tools to help guide them through achieving successful transfers. It is applicable to those making transfers from development to commercial, from commercial to commercial, for scale-up, analytical methods or for ‘virtual’ companies.
The programme covers pharmaceutical products, including ATMPs and combination products, but does not include medical devices.
Benefits of attending:
- Understand that technology transfer (TT) is part of the product life cycle, supported by the pharmaceutical quality system
- Know where TT is covered in ICH, FDA, EU, WHO and PIC/S guidelines
- Learn the key steps for successful transfers
- Know how to engage sending and receiving units (SU and RU) for TT
- Understand how product and process understanding enables TT
- Apply tools such as quality risk management and clarify risks involved in TT
- Understand how change should be handled, eg facility and equipment differences between SU and RU; scale-up
- Learn how analytical method transfers are an integral part of TT
- Recognise how TT impacts a wide range of companies from innovative to generic, including development, manufacturing, major corporations and ‘virtual’ companies
- Realise how significant business benefits emerge from successful TT
- Understand TT for pharmaceutical products, including combination products and ATMPs
This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines.
Who should attend
This seminar will be of particular interest to all those from the pharmaceutical industry working in:
- Development
- Manufacturing
- Engineering
- Quality
The following personnel from the pharmaceutical and biopharmaceutical industries will also find it beneficial:
- Pharmacists
- Scientists
- Engineers
- Quality assurance professionals
- Quality control managers
- Late-stage product and process development engineers, scientists, pharmacists
- Technology scale-up and transfer managers
- Validation and qualification specialists
- Risk management specialists
- Operation managers
This course will cover:
Regulatory guidance and business drivers for TT
ICH Q10
Exercise 1 - What Makes a Successful TT?
Industry guidance for sending and receiving units (SU and RU)
Knowledge
- What do SU and RU need?
Exercise 2: Knowledge
Science and risk-based approaches - part one
Science and risk-based approaches - part two
Equipment and utilities
Exercise 3: Equipment at SU and RU
Quality risk management
Project management steps for TT - part one
Exercise 4 - Case Study - Fishbone for TT
Project management steps for TT - part two
Exercise 5: Case Study - Organising TT
Validation and qualification
Exercise 6: SU And RU
Analytical method transfer - part one
Analytical method transfer - part two
Enabling successful TT – ‘softer’ issues
Bruce Davis
Bruce Davis Ltd
Bruce Davis runs his own training/consultancy company for science and risk based approaches to Engineering and Process Validation (PV), Quality by Design (QbD), Technology Transfer (TT), Quality Risk Management and other related topics. He has run many training events for companies both in the UK and internationally. He is past Chair of ISPE International Board of Directors. He led, co-lead or contributed to a number of their guidances for PV, QbD & TT and most recently has co-written one chapter on TT for ATMPs (i.e personalised medicines) . He is a professional engineer with many years’ experience in the pharmaceutical industry and a wide international knowledge. He previously worked at AstraZeneca, where his responsibilities included managing international engineering and leading changes to qualification practices. He is an established trainer and likes to engage with participants, to try to ensure the training experience is related to their particular requirements, and to bring in the importance of science and risk based thinking.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
Please contact us for pricing if you are interested in booking 5 or more delegates
2-3 June 2025
Live online
09:00-16:30 UK (London) (UTC+01)
10:00-17:30 Paris (UTC+02)
04:00-11:30 New York (UTC-04)
Course code 14975
- GBP 1,499
- EUR 2,099
- USD 2,399
- 2 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
6-7 October 2025
Live online
09:00-16:30 UK (London) (UTC+01)
10:00-17:30 Paris (UTC+02)
04:00-11:30 New York (UTC-04)
Course code 14622
- GBP 1,299 1,499
- EUR 1,819 2,099
- USD 2,087 2,399
Until 01 Sep
- 2 days live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Reviews of IPI's Effective Technology Transfer training course
The theoretical part was interesting, but the practical excercises proposed during the course were so helpful for a better understanding, excercises challanged me to actively partecipate, and even sometime it was difficult because of my working background, I really appreciated.
Feb 3 2025
Alessia Reitano 
Senior CMC Specialist, Sintetica SA
Oct 7 2024
The training course exceeded my expectations.The course was well structured ,with a perfect balance of theory and practical applications. The speaker was knowledgeable, approachable, and provided clear detailed explanations.
Maria Galanou 
Quality Affairs for New Products Expert, Pharmathen
Jul 16 2024
Bruce had an outstanding performance as speaker! I truly recommend everyone to have the chance to exchange knowledge with Bruce.
David Miguel Soares Dias 
Regulatory Affairs Team Lead, Generis Farmacêutica S.A.
Jan 23 2024
Very good
Jeļena Gurko 
Leading Industrial Pharmacist, JSC
Oct 7 2024
I am very satisfied with the course. I came away with what I came for. [Speaker was] amazing. A person on the ground [with] very well presented material interspersed with occasional jokes.
Petra Hlouzkova 
Technical Services Supervisor, Novavax
Jul 16 2024
Yes, the webinar helped me understand the whole tech transfer from start to finish. Bruce's key elements and points were brilliant. Further, these points can easily be practised at any stage of the project.
Dhaval Pandeji 
Senior Regulatory Affairs Officer, Neon Healthacare Limited
Jul 16 2024
Mr. Davis was very helpful during the presentation, the explanations were very clear and understandable and he was always willing to answer our questions. The slides were very organized and the presentation was very clear
Paraskevi Vitoratou
Pharmaceutical and Manufacturing Technology Scientist, PharmaPath S.A.
Jul 16 2024
Mr. Davis was very helpful during the presentation, the explanations were very clear and understandable and he was always willing to answer our questions. The content was exactly what I was looking for and helped me gain more knowledge regarding my job.
Paraskevi Vitoratou
Pharmaceutical and Manufacturing Technology Scientist, PharmaPath S.A.
Jul 16 2024
Bruce has been an excellent speaker to help understand the key steps for a successful tech transfer. His expertise in the pharmaceutical industry and clear explanations made the learning experience very valuable. The continuous interaction between Bruce and the participants was excellent to dynamize the course and to expand knowledge within different industry areas.
Robert Bergé Sarroca 
Process Development Scientist, Instituto Grifols S.A.
Jan 23 2024
Bruce seemed very knowledgeable thanks to all his years working within the industry.
Andrés Bueno Venegas 
Scientific consultant, Emendo R&D
Apr 19 2023
The presentations were in a clear, understandable, well structured form
István Szabó 
Plant manager, Gedeon Richter
Oct 11 2022
The explanations of the proposed topics were very acceptable and the relation between the theoretical and practical parts was very outstanding.
Álvaro García Ramos
Head of R&D, Grupo Juste (Justesa Imagen SAU)
Apr 6 2022
It was a very useful training that fulfil my necessities about the Industry standards for the Technology transfers... Bruce is very knowledgeable and he was continuously asking the participants to provide feedback and their own experiences.
Sergio Molina Zaragoza 
Vice President Research and Development, Grifols Biologicals LLC
Jan 11 2022
The course contains a lot of brilliant insights into the issues with tech transfer process and how to effectively manage these issues with adequate planning, controls and communication.
Emir Bouleghlimat
Purolite Ltd
Jan 11 2022
A very well rounded course that formalised and expanded on a lot of knowledge/understanding that we were in the process of developing ourselves. The course contains a lot of brilliant insights into the issues with tech transfer process and how to effectively manage these issues with adequate planning, controls and communication. Overall I was very impressed with the course and Bruce, and would recommend anyone involved in a process where methods/tech are being transferred to sign up to this course.
Emir Bouleghlimat
Purolite Ltd
Jan 11 2022
Everything set in the agenda was covered. No issues with presentation, if any help required we were able to privately message Natalia. The speed at which Bruce spoke through the documents was good and I was happy there was multiple opportunities to make comments, discuss topic and conduct exercises on what we just learnt.
Amaira Umer
QA Officer, Purolite Ltd
Jan 11 2022
Bruce was very polite and interactive. The use of real-life examples, I thought was great to help apply and understand certain points.
Liam Evans
Purolite Ltd
Oct 5 2021
He [Bruce Davis] was very friendly, professional and thoughtful. He encouraged all the trainees to participate in the exercises in a very positive & constructive way.
Grace Jung 
Senior Scientist, Design Transfer, Speedx Pty Ltd
Oct 5 2021
[The speaker] was very friendly, professional and thoughtful. He encouraged all the trainees to participate in the exercises in a very positive & constructive way.
Grace Jung
Senior Scientist, Design Transfer, Speedx Pty Ltd
Nov 19 2019
The course was absolutely great and to get helpful advice from the experienced speaker was fantastic.
Ulrike Ratz 
CMC Manager, Cheplapharm Arzneimittel GmbH
May 21 2019
Good all round course covering all aspects of Tech Transfer.
Frances Morrissey
Product Specialist - Global Technical Management, Norgine Limited
May 21 2019
Really worthwhile course that I would recommend to my colleagues. I have several practical tools that will help me in my future technology transfers.
Laura Hearthward
Product Development Manager, Torbay Pharmaceuticals
United Kingdom
- Arecor Ltd
- Compass Pathways
- Dechra Limited
- EuroAPI
- Genethics Regulatory Services
- Morningside Healthcare Limited
- Mundipharma Research Ltd
- Neon Healthacare Limited
- Norgine Limited
- Norgine Ltd
- Purolite Ltd
- Rentschler ATMP Ltd
- Sekisui Diagnostics
- Torbay Pharmaceuticals
Germany
- Aristo Pharma GmbH
- Bayer Consumer Care AG
- BMS
- Cheplapharm Arzneimittel GmbH
- Fresenius Kabi Deutschland GmbH
- Minaris Regenerative Medicine GmbH
Denmark
- Emendo R&D
- Fujifilm Diosynth Biotechnologies
- Pharmacosmos
- Statens Serum Institut
Switzerland
- Bazell Pharma AG
- Celonic AG
- Ichnos Sciences
- Sintetica SA
Italy
- Chiesi Farmaceutici S.p.a.
- Menarini Ricerche SpA
- RECORDATI S.P.A.
Netherlands
- Amgen
- Kinesis Pharma
- Sever Pharma Solutions
Norway
- Fresenius Kabi Ltd
- Fresenius Kabi Norway
- Oslo universitetssykehus
Spain
- Grupo Juste (Justesa Imagen SAU)
- Instituto Grifols S.A
- Instituto Grifols S.A.
Australia
- Speedx Pty Ltd
- SpeeDx Pty ltd.
Greece
- PharmaPath S.A.
- Pharmathen
Hungary
- Gedeon Richter
- Gedeon Richter Plc
Portugal
- CIPAN,SA
- Generis Farmacêutica S.A.
Austria
- Boehringer Ingelheim Pharma Co.KG
Czech Republic
- Novavax
Ethiopia
- Armauer Hansen Research Institut
Finland
- FinVector Oy
Iceland
- Oculis
India
- Morningside Healthcare
Ireland
- Avectas
Latvia
- JSC
Sweden
- Knightec AB
United States of America
- Grifols Biologicals LLC
Run Effective Technology Transfer Live online for your team
2 days
Typical duration
Pricing from:
- GBP 1,000
- Per attendee, based on 10 attendees
- Course tailored to your requirements
- At your choice of location, or online
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
